Assure (wearable defibrillator)

2021: Announcement of a compact defibrillator that does not need to be injected under the skin

In early August 2021, the American company Kestra Medical Technologies released a compact wearable cardioverter defibrillator Assure, which does not need to be injected under the skin.

According to the press release, Kestra positions its Assure WCD system as a modern convenient wearable device with built-in sensors, a heart rate monitor and a miniature automatic external defibrillator. The system was designed to protect patients at risk of sudden cardiac death (BCC). She can analyze the patient's heart rate, independently detect dangerous arrhythmias and autonomously decide on the need for treatment. The developers state that with proper use, the Assure WCD system can safely conduct defibrillation therapy to restore a normal heart rhythm. In addition, the system is compatible with the Kestra cloud-based digital healthcare platform, which provides communication of a wearable cardioverter defibrillator with both patients and their treating doctors. Kestra expects Assure to appear in a number of global markets in the fall of 2021.

Kestra Medical Technologies introduced a compact defibrillator that does not need to be injected under the skin

We know that wearable cardioverter defibrillators can save a patient's life, but to do this, we must convince this patient that he must always wear this device despite the inconvenience, "Kestra CEO Brian Webster explained in a press release. - Kestra developed the Assure system using the latest available technologies to provide patients with a convenient and easy-to-use solution that is not characterized by the usual problems of such devices. Our system also sends high-precision notifications to attending physicians, making it possible to significantly improve patient care.[1]

Notes